Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne.
Identifieur interne : 004002 ( Main/Exploration ); précédent : 004001; suivant : 004003Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne.
Auteurs : RBID : pubmed:9255157English descriptors
- KwdEn :
- 3-Iodobenzylguanidine, Abdominal Neoplasms (diagnosis), Abdominal Neoplasms (secondary), Carcinoid Tumor (diagnosis), Carcinoid Tumor (secondary), Carcinoma, Medullary (diagnosis), Carcinoma, Medullary (secondary), Feasibility Studies, Humans, Image Processing, Computer-Assisted, Indium Radioisotopes (diagnostic use), Iodine Radioisotopes (diagnostic use), Iodobenzenes (diagnostic use), Octreotide (analogs & derivatives), Octreotide (diagnostic use), Pentetic Acid (analogs & derivatives), Pentetic Acid (diagnostic use), Radiopharmaceuticals (diagnostic use), Reproducibility of Results, Retrospective Studies, Technetium Tc 99m Medronate (analogs & derivatives), Technetium Tc 99m Medronate (diagnostic use), Thoracic Neoplasms (diagnosis), Thoracic Neoplasms (secondary), Thyroid Neoplasms (diagnosis), Thyroid Neoplasms (pathology), Tomography, Emission-Computed, Single-Photon (methods), Tomography, X-Ray Computed (methods).
- MESH :
- chemical , analogs & derivatives : Octreotide, Pentetic Acid, Technetium Tc 99m Medronate.
- chemical , diagnostic use : Indium Radioisotopes, Iodine Radioisotopes, Iodobenzenes, Octreotide, Pentetic Acid, Radiopharmaceuticals, Technetium Tc 99m Medronate.
- chemical : 3-Iodobenzylguanidine.
- diagnosis : Abdominal Neoplasms, Carcinoid Tumor, Carcinoma, Medullary, Thoracic Neoplasms, Thyroid Neoplasms.
- methods : Tomography, Emission-Computed, Single-Photon, Tomography, X-Ray Computed.
- pathology : Thyroid Neoplasms.
- secondary : Abdominal Neoplasms, Carcinoid Tumor, Carcinoma, Medullary, Thoracic Neoplasms.
- Feasibility Studies, Humans, Image Processing, Computer-Assisted, Reproducibility of Results, Retrospective Studies.
Abstract
Superimposition of SPECT and computed tomography (CT) slices from the thoracoabdominal region was achieved without the use of external markers for 14 studies in 13 patients with endocrine carcinoma. Technical feasibility and clinical validation of this retrospective fusion method were assessed.
PubMed: 9255157
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne.</title><author><name sortKey="Perault, C" uniqKey="Perault C">C Pérault</name><affiliation wicri:level="1"><nlm:affiliation>Nuclear Medicine and Biophysics Unit, Jean Godinot Institute, Reims, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Nuclear Medicine and Biophysics Unit, Jean Godinot Institute, Reims</wicri:regionArea><placeName><region type="région">Champagne-Ardenne</region><settlement type="city">Reims</settlement></placeName></affiliation></author><author><name sortKey="Schvartz, C" uniqKey="Schvartz C">C Schvartz</name></author><author><name sortKey="Wampach, H" uniqKey="Wampach H">H Wampach</name></author><author><name sortKey="Liehn, J C" uniqKey="Liehn J">J C Liehn</name></author><author><name sortKey="Delisle, M J" uniqKey="Delisle M">M J Delisle</name></author></titleStmt><publicationStmt><date when="1997">1997</date><idno type="RBID">pubmed:9255157</idno><idno type="pmid">9255157</idno><idno type="wicri:Area/Main/Corpus">004303</idno><idno type="wicri:Area/Main/Curation">004303</idno><idno type="wicri:Area/Main/Exploration">004002</idno></publicationStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>3-Iodobenzylguanidine</term><term>Abdominal Neoplasms (diagnosis)</term><term>Abdominal Neoplasms (secondary)</term><term>Carcinoid Tumor (diagnosis)</term><term>Carcinoid Tumor (secondary)</term><term>Carcinoma, Medullary (diagnosis)</term><term>Carcinoma, Medullary (secondary)</term><term>Feasibility Studies</term><term>Humans</term><term>Image Processing, Computer-Assisted</term><term>Indium Radioisotopes (diagnostic use)</term><term>Iodine Radioisotopes (diagnostic use)</term><term>Iodobenzenes (diagnostic use)</term><term>Octreotide (analogs & derivatives)</term><term>Octreotide (diagnostic use)</term><term>Pentetic Acid (analogs & derivatives)</term><term>Pentetic Acid (diagnostic use)</term><term>Radiopharmaceuticals (diagnostic use)</term><term>Reproducibility of Results</term><term>Retrospective Studies</term><term>Technetium Tc 99m Medronate (analogs & derivatives)</term><term>Technetium Tc 99m Medronate (diagnostic use)</term><term>Thoracic Neoplasms (diagnosis)</term><term>Thoracic Neoplasms (secondary)</term><term>Thyroid Neoplasms (diagnosis)</term><term>Thyroid Neoplasms (pathology)</term><term>Tomography, Emission-Computed, Single-Photon (methods)</term><term>Tomography, X-Ray Computed (methods)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Octreotide</term><term>Pentetic Acid</term><term>Technetium Tc 99m Medronate</term></keywords><keywords scheme="MESH" type="chemical" qualifier="diagnostic use" xml:lang="en"><term>Indium Radioisotopes</term><term>Iodine Radioisotopes</term><term>Iodobenzenes</term><term>Octreotide</term><term>Pentetic Acid</term><term>Radiopharmaceuticals</term><term>Technetium Tc 99m Medronate</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>3-Iodobenzylguanidine</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Abdominal Neoplasms</term><term>Carcinoid Tumor</term><term>Carcinoma, Medullary</term><term>Thoracic Neoplasms</term><term>Thyroid Neoplasms</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Tomography, Emission-Computed, Single-Photon</term><term>Tomography, X-Ray Computed</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Thyroid Neoplasms</term></keywords><keywords scheme="MESH" qualifier="secondary" xml:lang="en"><term>Abdominal Neoplasms</term><term>Carcinoid Tumor</term><term>Carcinoma, Medullary</term><term>Thoracic Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Feasibility Studies</term><term>Humans</term><term>Image Processing, Computer-Assisted</term><term>Reproducibility of Results</term><term>Retrospective Studies</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Superimposition of SPECT and computed tomography (CT) slices from the thoracoabdominal region was achieved without the use of external markers for 14 studies in 13 patients with endocrine carcinoma. Technical feasibility and clinical validation of this retrospective fusion method were assessed.</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">9255157</PMID><DateCreated><Year>1997</Year><Month>09</Month><Day>08</Day></DateCreated><DateCompleted><Year>1997</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0161-5505</ISSN><JournalIssue CitedMedium="Print"><Volume>38</Volume><Issue>8</Issue><PubDate><Year>1997</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</Title><ISOAbbreviation>J. Nucl. Med.</ISOAbbreviation></Journal><ArticleTitle>Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne.</ArticleTitle><Pagination><MedlinePgn>1234-42</MedlinePgn></Pagination><Abstract><AbstractText Label="UNLABELLED">Superimposition of SPECT and computed tomography (CT) slices from the thoracoabdominal region was achieved without the use of external markers for 14 studies in 13 patients with endocrine carcinoma. Technical feasibility and clinical validation of this retrospective fusion method were assessed.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients had a history of thyroid cancer or of carcinoid tumor. To detect tumor sites, CT scan and dual-isotope tomoscintigraphy were performed, with 99mTc-hydroxymethylene diphosphonate for bone scintigraphy and with 111In-pentetreotide, 131I or 131I-metaiodobenzylguanidine for tumor scintigraphy (TS). A superimposition method previously developed for the pelvic region was adapted to the nonrigid thoraco-abdominal region. CT-bone scintigraphy and CT-TS superimposed images were obtained. Clinical validation of the information obtained from the superimposed images was obtained from surgery or follow-up imaging studies performed after clinical evolution of the disease process.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Reliable and reproducible registration was achieved in all patients. CT-TS superimposed images produced accurate localization of abnormal TS foci. Accuracy was limited primarily by variable relative displacements of the thoracoabdominal organs. For 10 sites in 8 patients, localization and/or characterization obtained from CT-TS images was confirmed by a reference technique. Superimposition enabled the localization of tumor sites that otherwise could not have been suspected from CT alone and allowed the characterization of CT suspicious masses and the confirmation of CT positive sites. Nonspecific tumor TS uptake sites were also localized.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">With standard CT and dual-isotope SPECT acquisitions, SPECT-CT fusion is feasible in the thoracoabdominal region without the use of external markers. Fused images were validated in 8 patients for 10 sites. The use of this technique could probably improve the management and care of patients with endocrine carcinoma.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pérault</LastName><ForeName>C</ForeName><Initials>C</Initials><Affiliation>Nuclear Medicine and Biophysics Unit, Jean Godinot Institute, Reims, France.</Affiliation></Author><Author ValidYN="Y"><LastName>Schvartz</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Wampach</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Liehn</LastName><ForeName>J C</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><LastName>Delisle</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType>Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>UNITED STATES</Country><MedlineTA>J Nucl Med</MedlineTA><NlmUniqueID>0217410</NlmUniqueID><ISSNLinking>0161-5505</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance>Indium Radioisotopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance>Iodine Radioisotopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance>Iodobenzenes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance>Radiopharmaceuticals</NameOfSubstance></Chemical><Chemical><RegistryNumber>142694-57-3</RegistryNumber><NameOfSubstance>SDZ 215-811</NameOfSubstance></Chemical><Chemical><RegistryNumber>35MRW7B4AD</RegistryNumber><NameOfSubstance>3-Iodobenzylguanidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>72945-61-0</RegistryNumber><NameOfSubstance>technetium Tc 99m hydroxymethylene diphosphonate</NameOfSubstance></Chemical><Chemical><RegistryNumber>7A314HQM0I</RegistryNumber><NameOfSubstance>Pentetic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>RWM8CCW8GP</RegistryNumber><NameOfSubstance>Octreotide</NameOfSubstance></Chemical><Chemical><RegistryNumber>X89XV46R07</RegistryNumber><NameOfSubstance>Technetium Tc 99m Medronate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N">3-Iodobenzylguanidine</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Abdominal Neoplasms</DescriptorName><QualifierName MajorTopicYN="N">diagnosis</QualifierName><QualifierName MajorTopicYN="N">secondary</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Carcinoid Tumor</DescriptorName><QualifierName MajorTopicYN="Y">diagnosis</QualifierName><QualifierName MajorTopicYN="N">secondary</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Carcinoma, Medullary</DescriptorName><QualifierName MajorTopicYN="Y">diagnosis</QualifierName><QualifierName MajorTopicYN="N">secondary</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="Y">Image Processing, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Indium Radioisotopes</DescriptorName><QualifierName MajorTopicYN="N">diagnostic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Iodine Radioisotopes</DescriptorName><QualifierName MajorTopicYN="N">diagnostic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Iodobenzenes</DescriptorName><QualifierName MajorTopicYN="N">diagnostic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Octreotide</DescriptorName><QualifierName MajorTopicYN="N">analogs & derivatives</QualifierName><QualifierName MajorTopicYN="N">diagnostic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Pentetic Acid</DescriptorName><QualifierName MajorTopicYN="N">analogs & derivatives</QualifierName><QualifierName MajorTopicYN="N">diagnostic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Radiopharmaceuticals</DescriptorName><QualifierName MajorTopicYN="N">diagnostic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Technetium Tc 99m Medronate</DescriptorName><QualifierName MajorTopicYN="N">analogs & derivatives</QualifierName><QualifierName MajorTopicYN="N">diagnostic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Thoracic Neoplasms</DescriptorName><QualifierName MajorTopicYN="N">diagnosis</QualifierName><QualifierName MajorTopicYN="N">secondary</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Thyroid Neoplasms</DescriptorName><QualifierName MajorTopicYN="Y">diagnosis</QualifierName><QualifierName MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Tomography, Emission-Computed, Single-Photon</DescriptorName><QualifierName MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName><QualifierName MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1997</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1997</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1997</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">9255157</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=IndiumV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004002 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004002 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= *** parameter Area/wikiCode missing ***
|area= IndiumV2
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:9255157
|texte= Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:9255157" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a IndiumV2
| This area was generated with Dilib version V0.5.76. |  |